Trends in the incidence and management of biliary tract cancer: A French population-based study

被引:64
作者
Lepage, Come [1 ,2 ]
Cottet, Vanessa
Chauvenet, Marion [2 ]
Phelip, Jean-Marc [3 ]
Bedenne, Laurent [2 ]
Faivre, Jean [2 ]
Bouvier, Anne-Marie
机构
[1] Univ Bourgogne, Registre Bourguignon Canc Digestifs, INSERM,U866, Fac Med, F-21079 Dijon, France
[2] Univ Hosp Le Bocage, Dept Hepatogastroenterol, Dijon, France
[3] Univ St Etienne, St Etienne, France
关键词
Biliary tract cancer; Incidence; Survival rate; Treatment; INTRAHEPATIC CHOLANGIOCARCINOMA; MORTALITY-RATES; CHEMOTHERAPY; DIAGNOSIS; SURVIVAL; INCREASE; THERAPY; ENGLAND; LIVER; ERCP;
D O I
10.1016/j.jhep.2010.06.039
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: The trends in incidence and management of biliary tract cancer (BTC) were investigated in a well-defined French population over a 30-year period (1976-2005). Methods: Data were obtained from the Burgundy digestive cancer registry. Age-standardised incidence rates and trends in incidence were determined. Treatment and stage at diagnosis were also investigated. Five-year survival rates were calculated. Results: Six hundred and fifteen cases of BTC were recorded. There was no significant change in BTC incidence over the 30-year period. For extrahepatic BTC age-standardised incidence rates were 1.1/100,000 for 1976-80 and 2001-2005. These rates were respectively 0.3 and 0.2/100,000 for intrahepatic BTC. The proportion of patients undergoing resection for cure increased over time from 4.8% to 14.2% (p<0.001). The proportion of stage I-II cases ranged from 3.2% to 7.1% but did not vary significantly over time (p=0.55). Most cases were metastatic or unresectable at diagnosis. Five-year relative survival rates were 4.5% for 1976-85 and 6.7% for 1996-2005, ranging from 35.1% for stages I-II to 4.3% for advanced BTC. Age and stage at diagnosis were independent prognostic factors. Conclusions: The incidence of BTC has remained stable in Burgundy over the past 30 years. BTC prognosis remains poor and has only improved slightly over time. (C) 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:306 / 310
页数:5
相关论文
共 31 条
[1]  
[Anonymous], 2007, STAT STAT SOFTW REL
[2]   MANAGEMENT STRATEGIES IN RESECTION FOR HILAR CHOLANGIOCARCINOMA [J].
BISMUTH, H ;
NAKACHE, R ;
DIAMOND, T .
ANNALS OF SURGERY, 1992, 215 (01) :31-38
[3]   Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer [J].
D'Angelica, M ;
Martin, RCG ;
Jarnagin, WR ;
Fong, Y ;
DeMatteo, RP ;
Blumgart, LH .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 198 (04) :570-576
[4]   Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2) [J].
de Bellis, M ;
Sherman, S ;
Fogel, EL ;
Cramer, H ;
Chappo, J ;
McHenry, L ;
Watkins, JL ;
Lehman, GA .
GASTROINTESTINAL ENDOSCOPY, 2002, 56 (05) :720-730
[5]   Tissue sampling at ERCP in suspected malignant biliary strictures (Part 1) [J].
de Bellis, M ;
Sherman, S ;
Fogel, EL ;
Cramer, H ;
Chappo, J ;
McHenry, L ;
Watkins, JL ;
Lehman, GA .
GASTROINTESTINAL ENDOSCOPY, 2002, 56 (04) :552-561
[6]   Medical progress - Biliary tract cancers [J].
de Groen, PC ;
Gores, GJ ;
LaRusso, NF ;
Gunderson, LL ;
Nagorney, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (18) :1368-1378
[7]   RELATIVE SURVIVAL AND THE ESTIMATION OF NET SURVIVAL - ELEMENTS FOR FURTHER DISCUSSION [J].
ESTEVE, J ;
BENHAMOU, E ;
CROASDALE, M ;
RAYMOND, L .
STATISTICS IN MEDICINE, 1990, 9 (05) :529-538
[8]  
Ishak KG., 1994, WHO International Histological Classification of Tumours, V2nd edn
[9]   Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma [J].
Jarnagin, WR ;
Fong, Y ;
DeMatteo, RP ;
Gonen, M ;
Burke, EC ;
Bodniewicz, J ;
Youssef, M ;
Klimstra, D ;
Blumgart, LH .
ANNALS OF SURGERY, 2001, 234 (04) :507-517
[10]   Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002 [J].
Jepsen, Peter ;
Vilstrup, Hendrik ;
Tarone, Robert E. ;
Friis, Soren ;
Sorensen, Henrik Toft .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (11) :895-897